Trinity Biotech Price to Book Ratio 2012-2025 | TRIB
Historical price to book ratio values for Trinity Biotech (TRIB) over the last 10 years. The current price to book ratio for Trinity Biotech as of January 16, 2026 is 0.00.
| Trinity Biotech Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-01-16 | 0.69 | 0.00 | |
| 2025-09-30 | 1.04 | 0.00 | |
| 2025-06-30 | 0.65 | 0.00 | |
| 2025-03-31 | 0.57 | 0.00 | |
| 2024-12-31 | 0.88 | 0.00 | |
| 2024-09-30 | 1.10 | 0.00 | |
| 2024-06-30 | 2.13 | $-14.56 | -0.15 |
| 2024-03-31 | 2.04 | 0.00 | |
| 2023-12-31 | 2.15 | $-14.44 | -0.15 |
| 2023-09-30 | 3.68 | 0.00 | |
| 2023-06-30 | 4.76 | 0.00 | |
| 2023-03-31 | 4.70 | 0.00 | |
| 2022-12-31 | 4.95 | $-1.32 | -3.75 |
| 2022-09-30 | 5.36 | 0.00 | |
| 2022-06-30 | 6.13 | $9.59 | 0.64 |
| 2022-03-31 | 5.30 | 0.00 | |
| 2021-12-31 | 7.15 | $-0.33 | -21.56 |
| 2021-09-30 | 10.80 | 0.00 | |
| 2021-06-30 | 14.70 | 0.00 | |
| 2021-03-31 | 18.80 | 0.00 | |
| 2020-12-31 | 19.05 | $-2.31 | -8.26 |
| 2020-09-30 | 10.10 | 0.00 | |
| 2020-06-30 | 10.90 | 0.00 | |
| 2020-03-31 | 5.50 | 0.00 | |
| 2019-12-31 | 5.17 | $4.90 | 1.05 |
| 2019-09-30 | 6.05 | 0.00 | |
| 2019-06-30 | 8.25 | 0.00 | |
| 2019-03-31 | 14.25 | 0.00 | |
| 2018-12-31 | 11.45 | $45.81 | 0.25 |
| 2018-09-30 | 20.00 | 0.00 | |
| 2018-06-30 | 25.00 | 0.00 | |
| 2018-03-31 | 25.75 | 0.00 | |
| 2017-12-31 | 25.50 | $67.80 | 0.38 |
| 2017-09-30 | 28.05 | 0.00 | |
| 2017-06-30 | 30.00 | 0.00 | |
| 2017-03-31 | 29.80 | 0.00 | |
| 2016-12-31 | 34.60 | $113.06 | 0.31 |
| 2016-09-30 | 66.10 | 0.00 | |
| 2016-06-30 | 56.70 | 0.00 | |
| 2016-03-31 | 58.30 | 0.00 | |
| 2015-12-31 | 58.80 | $223.18 | 0.26 |
| 2015-09-30 | 57.20 | 0.00 | |
| 2015-06-30 | 90.30 | 0.00 | |
| 2015-03-31 | 95.07 | 0.00 | |
| 2014-12-31 | 86.47 | $208.86 | 0.41 |
| 2014-09-30 | 90.23 | 0.00 | |
| 2014-06-30 | 113.73 | 0.00 | |
| 2014-03-31 | 118.55 | 0.00 | |
| 2013-12-31 | 123.00 | 0.00 | |
| 2013-09-30 | 106.46 | 0.00 | |
| 2013-06-30 | 82.44 | 0.00 | |
| 2013-03-31 | 81.62 | 0.00 | |
| 2012-12-31 | 69.72 | 0.00 | |
| 2012-09-30 | 60.78 | 0.00 | |
| 2012-06-30 | 58.02 | 0.00 | |
| 2012-03-31 | 50.90 | 0.00 | |
| 2011-12-31 | 48.56 | 0.00 | |
| 2011-09-30 | 43.70 | 0.00 | |
| 2011-06-30 | 47.42 | 0.00 | |
| 2011-03-31 | 42.96 | 0.00 | |
| 2010-12-31 | 40.35 | 0.00 | |
| 2010-09-30 | 28.99 | 0.00 | |
| 2010-06-30 | 27.85 | 0.00 | |
| 2010-03-31 | 24.96 | 0.00 | |
| 2009-12-31 | 18.50 | 0.00 | |
| 2009-09-30 | 18.09 | 0.00 | |
| 2009-06-30 | 20.24 | 0.00 | |
| 2009-03-31 | 7.97 | 0.00 | |
| 2008-12-31 | 7.33 | 0.00 | |
| 2008-09-30 | 12.92 | 0.00 | |
| 2008-06-30 | 17.68 | 0.00 | |
| 2008-03-31 | 21.02 | 0.00 | |
| 2007-12-31 | 31.19 | 0.00 | |
| 2007-09-30 | 48.09 | 0.00 | |
| 2007-06-30 | 53.13 | 0.00 | |
| 2007-03-31 | 41.58 | 0.00 | |
| 2006-12-31 | 39.25 | 0.00 | |
| 2006-09-30 | 42.59 | 0.00 | |
| 2006-06-30 | 34.58 | 0.00 | |
| 2006-03-31 | 41.72 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.062B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $211.725B | 24.40 |
| EssilorLuxottica (ESLOY) | France | $146.103B | 0.00 |
| Stryker (SYK) | United States | $139.118B | 27.62 |
| Boston Scientific (BSX) | United States | $130.559B | 29.85 |
| Medtronic (MDT) | Ireland | $124.048B | 17.19 |
| Medline (MDLN) | United States | $57.961B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.907B | 0.00 |
| Agilent Technologies (A) | United States | $39.588B | 25.03 |
| ResMed (RMD) | United States | $37.591B | 26.02 |
| GE HealthCare Technologies (GEHC) | United States | $37.239B | 17.81 |
| Koninklijke Philips (PHG) | Netherlands | $28.483B | 18.60 |
| Terumo (TRUMY) | Japan | $20.476B | 23.05 |
| Insulet (PODD) | United States | $20.239B | 62.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.303B | 10.79 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.893B | 0.00 |
| Baxter (BAX) | United States | $10.338B | 8.34 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.457B | 30.41 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.261B | 12.98 |
| Envista Holdings (NVST) | United States | $4.150B | 23.81 |
| BillionToOne (BLLN) | United States | $4.061B | 0.00 |
| ICU Medical (ICUI) | United States | $3.855B | 24.48 |
| Haemonetics (HAE) | United States | $3.378B | 15.04 |
| Prestige Consumer Healthcare (PBH) | United States | $3.131B | 14.28 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.255B | 14.50 |
| Perrigo (PRGO) | Ireland | $2.068B | 5.18 |
| Neogen (NEOG) | United States | $2.012B | 44.05 |
| LeMaitre Vascular (LMAT) | United States | $2.002B | 40.31 |
| AtriCure (ATRC) | United States | $1.942B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.805B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.678B | 73.55 |
| Phibro Animal Health (PAHC) | United States | $1.665B | 16.63 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.471B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.437B | 20.80 |
| Kestra Medical Technologies (KMTS) | United States | $1.333B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.176B | 348.86 |
| Capricor Therapeutics (CAPR) | United States | $1.113B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.062B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.002B | 0.00 |
| InMode (INMD) | Israel | $0.881B | 9.96 |
| Valneva SE (VALN) | France | $0.867B | 0.00 |
| Omeros (OMER) | United States | $0.852B | 0.00 |
| CeriBell (CBLL) | United States | $0.814B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.578B | 15.67 |
| Cerus (CERS) | United States | $0.499B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.479B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Brainsway (BWAY) | Israel | $0.454B | 77.27 |
| Canopy Growth (CGC) | Canada | $0.438B | 0.00 |
| Quanterix (QTRX) | United States | $0.346B | 0.00 |
| Evolus (EOLS) | United States | $0.337B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.279B | 22.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.276B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.00 |
| TerrAscend (TSNDF) | Canada | $0.239B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.232B | 0.00 |
| High Tide (HITI) | Canada | $0.224B | 0.00 |
| Organigram Global (OGI) | Canada | $0.218B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.203B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 17.27 |
| Accendra Health (ACH) | United States | $0.195B | 1.95 |
| OraSure Technologies (OSUR) | United States | $0.193B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.192B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.146B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.79 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Exagen (XGN) | United States | $0.106B | 0.00 |
| Biote (BTMD) | United States | $0.106B | 4.64 |
| Sharps Technology (STSS) | United States | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 24.46 |
| Nephros (NEPH) | United States | $0.048B | 34.46 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Veru (VERU) | United States | $0.043B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.031B | 15.67 |
| Jin Medical (ZJYL) | China | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Bonk (BNKK) | United States | $0.018B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |